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Introduction
Ventilator-associated pneumonia is a common infection
in Intensive Care environment, with a high attributable
morbidity and mortality. In recent years, several strate-
gies of prevention have demonstrated benefit.
Objectives
To describe the impact of a VAP prevention bundle that
includes selective digestive decontamination (SDD) in
our setting.
Methods
On June 2010, a VAP prevention bundle was implemen-
ted in province of Murcia (Spain) This bundle included:
appropriate airway secretions management, strict hand
hygiene, cuff pressure control, oral hygiene with chlor-
hexidine, semi-recumbent positioning and selective
decontamination of the digestive tract (SDD) with a
short course of parenteral antibiotic.
On april 2011 was implemented “Neumonía Zero”
project at National level, which includes those same
recommendatios but with SDD only as an optional
highly recommended measure.
We collect data from four public health system hospi-
tals, before (january 2006 to June 2010) and after (july
2010 to december 2014) the implementation of the
bundle.
Results
In the preimplantation period 9924 patients was ana-
lyzed, with 19924 days of mechanical ventilation (MV).
In the period after the implementation of the bundle,
17060 patients and 40044 days of MV was studied.
VAP rate passed from a mean of 15.1 cases per 1000
ventilator-days, to 8.8, 6.4 and 5.4 cases per 1000 venti-
lator-days in the three consecutive 18-months periods
after the introduction of the bundle.
We analyzed the etiology of VAP across time. P. aerugi-
nosa was the causal bacteria in 30.5 % of cases in preim-
plementation period and 32.5 % in postimplementation
one. S. Aureus passed from 11.5 to 9.3 %; A. baumanii
from 3.6 to 4.2%; Other enterobacteriae from 38 to 26.1 %;
and other etiologies from 18.8 to 27.7 %.
Conclusions
Introduction of a ventilador-associated pneumonia pre-
vention bundle that includes selective digestive deconta-
mination led to a progressive reduction in our high rate
of VAP. No clear evidence of change in microbiological
etiology has been observed as a result of initiation of
selective digestive decontamination.
Authors’ details
1Hospital General Universitario Santa Lucía, Servicio de Medicina Intensiva,
Cartagena, Spain. 2Hospital Universitario Virgen de la Arrixaca, Servicio de
Medicina Intensiva, Murcia, Spain. 3Hospital Universitario J.M. Morales
Meseguer, Servicio de Medicina Intensiva, Murcia, Spain. 4Hospital General
Universitario Reina Sofía, Servicio de Medicina Intensiva, Murcia, Spain.
Published: 1 October 2015
1Hospital General Universitario Santa Lucía, Servicio de Medicina Intensiva,
Cartagena, Spain
Full list of author information is available at the end of the article
Rebollo et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A705
http://www.icm-experimental.com/content/3/S1/A705
© 2015 Rebollo et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
References
1. Ding S: Chest 2013, 144(5):1461-8, Nov.
2. Caserta , et al: BMC Infectious Diseases. 2012, 12(234).
3. Alvarez-Lerma F: Med Intensiva 2014, 38(4):226-36, May.
doi:10.1186/2197-425X-3-S1-A705
Cite this article as: Rebollo et al.: Impact of implementation of a
ventilator-associated pneumonia prevention bundle that includes
selective digestive decontamination in a southern region of Spain.
Intensive Care Medicine Experimental 2015 3(Suppl 1):A705.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Rebollo et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A705
http://www.icm-experimental.com/content/3/S1/A705
Page 2 of 2
